U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363707) titled 'A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.' on Dec. 19, 2025.
Brief Summary: The goal of this clinical trial is to learn if drugs Dapagliflozin and Empagliflozin work to treat NAFLD in Type 2 diabetes patients. It will also learn about the safety of drugs dapagliflozin and empagliflozin. The main questions it aims to answer are:
Do drug dapagliflozin and empagliflozin lower the NAFLD degree for participants? What medical problems do participants have when taking the drugs dapagliflozin and empagliflozin?
Researchers will compare drug dapagliflozin to empagliflozin to see which...